POET Technologies: Photonics Pioneer Under Siege as Lawsuits and Production Targets Collide

POET Technologies faces a class-action lawsuit, shareholder vote on US relocation, and a commercial ramp amid legal and financial turmoil after a 47% stock drop.

The month of June is shaping up as a defining moment for POET Technologies, with a shareholder vote on a US relocation, a lead-plaintiff deadline in a growing class-action suit, and the commercial ramp of a potentially billion-dollar customer relationship all converging at once. The optical-chip specialist finds itself fighting on two fronts: fending off legal claims that wiped out nearly half its market value in a single day, while trying to prove its photonic technology can deliver the revenue to justify a stock that has tripled year-to-date.

Four US law firms have now filed securities class actions against the company, with Bronstein, Gewirtz & Grossman issuing the latest notice on Monday. The suit covers anyone who bought POET shares between April 1 and April 27, and lead plaintiffs must step forward by June 29 — just days after the annual meeting where shareholders will decide whether to reincorporate in the United States.

The trigger that sent shares into a tailspin

The legal firestorm stems from an interview CFO Thomas Mika gave on April 21. According to the complaints, Mika discussed POET’s business relationships with Celestial AI and Marvell in a public forum, allegedly violating a confidentiality agreement with Marvell. Marvell immediately cancelled all outstanding orders, and the stock collapsed 47.3% in a single session, shedding $7.15 per share. By Monday, the stock was trading at $12.21, well below the $21 combined price of shares and warrants in the company’s recent $400 million direct placement.

The lawsuits also charge that POET misrepresented its tax status, which risked classifying the company as a Passive Foreign Investment Company (PFIC) — a designation that imposes punitive tax treatment on US holders and deters institutional investors. Management has proposed moving the corporate domicile to the US to eliminate the PFIC issue, and shareholders will vote on that measure in June.

A capital cushion with a dilution sting

In May, POET completed a registered direct placement that raised $400 million by selling 19,047,620 common shares and warrants for the same number of shares. Each unit carried a combined price of $21, with the warrants exercisable at $26.15 over three years. The cash is earmarked for production, R&D, corporate development, and the light-source business.

But the capital injection came at a cost: the potential for significant dilution if the warrants are exercised, and a reminder that the company's revenue base remains tiny relative to its market valuation. In the first quarter, POET reported product and development revenue of just $503,389 — up from $166,760 a year earlier but still a fraction of the spending needed to scale a photonics fab.

Financials still in the red

The income statement explains the nervousness. POET swung to a net loss of $12.3 million in Q1, or $0.08 per share, compared with a net profit of $6.3 million — also $0.08 per share — in the year-ago quarter. The accumulated deficit now stands at $291 million, and the company disclosed a material weakness in internal controls. Operating cash flow remained negative at $8.8 million.

Operational counterpunches: Lumilens and a new COO

Despite the legal headwinds, POET has not slowed its commercial push. On May 14 it signed a strategic supply agreement with Lumilens for photonic integrated circuits aimed at AI data-center infrastructure. The initial purchase order is $50 million, and POET says the five-year volume could exceed $500 million. Engineering samples for 800G and 1.6T transceivers are expected by the end of 2026, with volume production slated for 2027.

To manage that ramp, the company appointed Dr. Sandeep Kumar as chief operating officer. Kumar spent 18 years at Silicon Labs overseeing global manufacturing and supply chains, and his immediate priority is scaling production in Malaysia. The move signals that POET intends to turn its technology into a tangible revenue stream — but it must do so against a backdrop of legal uncertainty and a stock that lost half its value on a single news item.

June's dual deadlines

The next few weeks will test whether operational momentum or legal gravity prevails. The lead-plaintiff deadline of June 29 comes just after the shareholder vote on the US reincorporation. If the move passes, it removes the PFIC cloud and could open the door to institutional capital. If it fails, or if the class action gains traction, the $400 million cash cushion may not be enough to offset the reputational damage.

For now, the stock is pricing in a binary outcome. The gap between the technology story — a $500 million customer relationship and a new COO — and the reality of a $12 million quarterly loss and four active lawsuits is as wide as the bandwidth POET's photonic engines promise to deliver.